Event-Driven Stocks

RESPONSE GENETICS INC

Healthcare · In Vitro & In Vivo Diagnostic Substances · SEC filings ↗ · Compare ⊕

Signs1 good5 warning2 severedetails ↓

Financials

SEC XBRL · annual
 FY14FY13FY12FY11FY10
Revenue$16.7M$19.8M$18.7M$22.6M$21.3M
Operating income−$13.0M−$7.9M−$7.7M−$5.7M−$4.9M
Net income−$13.7M−$8.0M−$7.8M−$5.7M−$4.7M
Total assets$13.4M$18.1M$16.6M$7.9M$10.6M
Total liabilities$14.6M$6.8M$5.4M$6.1M$6.0M
Equity$2.5M$5.8M−$542,211−$6.1M−$3.3M
EPS (diluted)$-0.35$-0.24$-0.29
Shares out.38.7M32.8M24.8M19.5M18.4M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2014
Operating margin
−77.8%
Net margin
−81.9%
Return on equity
−548.0%
Return on assets
−101.9%
Return on capital (ROCE)
−154.9%
Liabilities / assets
108.7%
Debt / equity
5.85×
Book value / share
$0.06
Revenue growth (YoY)
−15.6%
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2014
Altman Z″ (distress)
-22.47distress
Accruals / assets
4.5%clean
Beneish M-Score
-2.43normal
Piotroski F-Score
1/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
23
/ 100
Profitability 0Growth 0Catalyst 33Earnings quality 33Financial strength 50

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

2 severe5 warning1 good
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue declined year-over-year
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Insider transactions

SEC Form 4 · most recent
0 acquisitions3 disposalsnet 2.4M shares · last 3
InsiderDateTypeSharesPrice
Bridger Management, Llc10% ownerNov 18, 2015D1.8M$0.00
Bridger Management, Llc10% ownerNov 13, 2015D547,100$0.00
Bridger Management, Llc10% ownerNov 10, 2015D60,000$0.00

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)